Company / Revenue
Boston Scientific Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$20.1B
FY2025
5-year range
$10.7B / $20.1B
FY2021-FY2025
Trend
+19.9%
vs FY2024
Sector context
#19 of 156
Health Care
What the data says
Boston Scientific's revenue of $20.1B is higher than 88% of companies in the Health Care sector (FY2025). Revenue has increased for 5 consecutive years, from $9.8B in FY2020 to $20.1B in FY2025.
Based on SEC 10-K filings.
$20.1B in FY2025 with a 5-year CAGR of +15.4%. Top quartile in the Health Care sector.
Improved from $14.2B to $20.1B over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +16.5%
- 5-Year CAGR
- +15.4%
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 156This company $20.1B Sector average $19.0B
▼
+5.6% above sector average
Key checks
Key Insights
- Boston Scientific's revenue has grown for 5 consecutive years.
- 5-year CAGR of +15.4%, indicating consistent growth.
- In FY2025, revenue increased 19.9% year-over-year.
- Ranks #19 out of 156 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $20.1B | +19.9% |
| FY2024 | $16.7B | +17.6% |
| FY2023 | $14.2B | +12.3% |
| FY2022 | $12.7B | +18.1% |
| FY2021 | $10.7B | +9.3% |
| FY2020 | $9.8B | -8.5% |
| FY2019 | $10.7B | +9.3% |
| FY2018 | $9.8B | +8.6% |
| FY2017 | $9.0B | -0.3% |
| FY2016 | $9.1B | +12.5% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026